Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?

This article discusses the role of gene expression signatures in guiding treatment decisions for patients with resected node-positive breast cancer. The study examines how these molecular tools can help avoid over- and undertreatment by better predicting patient prognosis and response to therapy. It highlights the advances in gene expression profiling